Is Active Surveillance Feasible for Esophageal Cancer? Tara Haelle

https://www.medscape.com/viewarticle/active-surveillance-feasible-esophageal-cancer-2026a100146q?ecd=wnl_edit_tpal_etid8832692&uac=148436CN&impID=8832692 Active surveillance may be a feasible strategy for improving quality of life and potentially avoiding surgery in patients with locally advanced esophageal cancer who have a clinical complete response to neoadjuvant chemoradiation, according to updated findings from a phase 3 study. Among more than 300 patients in the non-inferiority SANO trial, those who underwent active surveillance had a similar 5-year overall survival rate as those who received standard surgery following chemoradiation. At a median of 76 months, roughly half of patients in both treatment groups were still alive.